WORLD’S LARGEST STUDY IN INTRAVENOUS CATHETER SECUREMENT FOR CHILDREN AND CATHETER FAILURE REDUCTION
Brooke Charters, Paediatric Emergency Nurse
Gold Coast Hospital and Health Service
PEOPLE IN HEALTH CARE
Filmed in Southport, Queensland | December 2024
Brooke Charters is a dynamic Paediatric Emergency Nurse who works at the Gold Coast University Hospital in Queensland.
After leaving school unsure of her career path, she ventured into disability support, which sparked her interest in nursing. She pursued a Bachelor of Nursing at Southern Cross University, and during her placement in Africa, she discovered her passion for paediatrics instead of mental health nursing.
Since completing her post grad certificate in paediatric acute care and a passion ignited from working frontline in the Paediatric Emergency, Brooke has developed a wide variety of clinical research interests, especially in cannulation, children’s mental health trauma and pain management.
An opportunity arose when she was approached for research ideas related to securing cannulas, a frequent issue in paediatric care.
Brooke was the first nurse to become a Principal Investigator on an Emergency Medicine Foundation (EMF) Queensland Research Program grant when it was opened to nurses. Having seen first-hand how one in four cannulas used in treating children were failing
and needed to be reinserted Brooke looked for an opportunity to find a solution.
The study enrolled children aged six months to eight years, aiming to save cannulas and reduce reinsertion trauma. Her study’s findings showed significant improvements in securing cannulas, highlighting a potential solution to a common problem.
Brooke initiated a study with a randomised control trial (RCT) comparing standard care to an integrated dressing with tissue adhesive.
Brooke’s research became the world’s largest study of its kind and in May 2024 the results of the study were published in JAMA Pediatrics. Her mission is to drive change and enhance the hospital experience for children globally.
-
Clinical research integrates with GP and Pharmacist workflows to supplement practice revenue
Clinical trials are crucial to the development of evidence-based preventative medicines. In addition, participation in clinical trials can also provide patients with opportunities to access new treatments.
“Clinical trials are at the heart of medical advances which look into new ways to treat, prevent, or detect disease. Volunteers often do so to help contribute to advancing scientific research, knowing that they are participating in the hope of helping future generations,” said Charlotte Bradshaw, CEO and Founder to Evrima Technologies.
-
Trends report identifies prototyping targets for breakthroughs in digital and hybrid futures
Vishaal Kishore, a Professor of Innovation and Public Policy at RMIT in Melbourne, serves as the Executive Chair of the RMIT-Cisco Health Transformation Lab and RMIT’s Director of Impact. Led by the RMIT-Cisco Health Transformation Lab, the National Industry Innovation Network (NIIN) Health Alliance combines the best minds, technologists, industry capabilities and academic resources to solve pressing industry and social challenges through technology-driven innovation. The NIIN aims to pool insights and expertise to address national health challenges, marking its first vertical focus on health.
-
Confronting picture of growing women’s health crisis in uterine cancers
Uterine cancers have become Australia’s fastest-growing women’s cancer, with incidence doubling over the past 25 years and projected to continue to surge. Without immediate action, more than 44,000 women are expected to be diagnosed by 2035, and 8,900 will lose their lives to the disease.
Released November 2025, Australia’s first State of the Nation: Uterine Cancers in Australia 2025 report by the Australia New Zealand Gynaecological Oncology Group (ANZGOG), reveals a confronting picture of a growing women’s health crisis that has gone largely unseen and one that now requires immediate, coordinated national action.
